Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

ASTRI Drives Forward 5G + C-V2X + AI Innovation and Transformation with Intel Technology

Published

on

Reading Time: 3 minutes

 

At Mobile World Congress (MWC) Shanghai 2019, Hong Kong Applied Science and Technology Research Institute (ASTRI) revealed their collaborations with Intel on 5G Standalone (SA) Core Network and Roadside Edge AI (Artificial Intelligence) for C-V2X (Cellular Vehicle-to-Everything) that power the new era of network transformation with the compelling capabilities of 5G, C-V2X and AI working together.

ASTRI’s 5G Standalone (SA) Core Network at 200Gbps on Intel Architecture

5G networks aim to provide diversified services. In 3GPP Release 15 standards, the 5G new Standalone (SA) core network enables a high degree of flexibility to meet application and service requirements. In fact, the Enhanced Mobile Broadband (eMBB) services have very high traffic capacity and data rate requirements (as much as 1000x comparing to 4G). The new 5G SA core network requires significantly more capacity, throughput performance and scalability to meet the challenging requirements for 5G.

ASTRI and Intel have collaborated on the research, development and optimization of 5G SA Core Network, especially on the User Plane Function (UPF) throughput, to meet 5G requirements. The collaboration results in, on a single sever, over 200Gbps throughput can be processed by ASTRI’s 5G UPF without packet loss. The key capabilities and elements to deliver breakthrough performance in the 5G Core Network include:

  • The UPF of ASTRI’s 5G SA Core Network can achieve high per-core performance
  • Dynamic Device Personalization (DDP) technology on Intel® Ethernet Network Adapters is utilized to achieve fine-grade load balancing to allow throughput scale up linearly with additional CPU cores
  • ASTRI 5G SA Core Network can scale down to a single hardware platform for small scale deployments, or scale out and distributed in cloud architecture

ASTRI and Intel are continuing the R&D collaboration to work closely on ASTRI’S 5G SA core network, such as supporting the N9 interface for mobile edge and additional Service-Based Network Functions, to enable a variety of network topologies to transform mobile core network to cater different 5G applications and scenarios.

Edge Intelligence and C-V2X Transforming Smart Mobility and Network Infrastructure

ASTRI and Intel collaborated to enable edge AI and visual-sensing capabilities for evolving next-generation smart roadside Infrastructure. The initial focus will be on enabling the real-time object recognition by ASTRI’s C-V2X Edge Software solution to detect imminent danger on roads and issue real-time alerts (like pedestrian crossing) to the respective drivers via C-V2X communications between vehicles and roadside infrastructure.

In addition to the low latency C-V2X communications, the C-V2X Edge Software demands high performance computing, AI and visual data processing to achieve end-to-end low latency. The Smart Roadside Computing Unit is powered by Intel® Xeon® D-2100 processors, delivering Intel’s ground-breaking data center processor architecture in a form factor optimized for cloud edge computing solutions. It brings the architectural innovations of the Intel Xeon Scalable platform to a system-on-a-chip (SoC) processor for low-power, high-density, small footprint solutions, integrating essential network, security, and acceleration capabilities. The AI and visual data processing in the Smart Roadside Computing Unit is accelerated by Intel®™ Myriad™ X Visual Processing Unit (VPU) and OpenVINO™ toolkit.

Accelerating Innovation and Transformation

5G SA Core Network is an important element for mobile core network transformation to support next wave of 5G services. ASTRI 5G SA core network, as pure software-based implementation, verified the suitability on high-volume platforms with Intel® Xeon® Scalable processors, to deliver outstanding performance and flexibility to allow quick time-to-market roll outs. Intelligent sensing and low latency communications using a C-V2X solution at the roadside (network edge) play an important role in shaping next generation roadside Infrastructure and smart mobility services.

Dr. Justin Chuang, VP of Next Generation Network at ASTRI: “ASTRI and Intel have mutual interests in network transformation since our collaboration on 4G EPC/C-RAN and virtualization.  Thanks to Intel, and as we are moving into the 5G era, the combinations of wireless, network, computing and intelligence to enable 5G and C-V2X applications shall be increasingly important. It’s exciting to see the collaboration with Intel getting deeper, wider and more impactful in 5G + C-V2X + AI to drive forward success in innovation and transformation.”

Caroline Chan, Vice President and General Manager of the Network Business Incubator Division at Intel: “Network transformation, AI and edge computing are converging to create some of the most amazing innovations we’ve seen in decades. Together with research leaders like ASTRI, Intel technology will fuel the next-generation of AI-powered applications and 5G-ready communications networks.”

Looking forward, it is expected to see more sensors on the roadside infrastructure to collect massive data and be transferred via 5G. Smart mobility applications will process the data at roadside edge and provide fast response to C-V2X enabled road users.

At Mobile World Congress Shanghai 2019, ASTRI will demonstrate our collaborations with Intel on 5G SA Core and Edge AI for roadside infrastructure in ASTRI booth [N1.D130].

Mobile World Congress Shanghai is Asia’s Leading Event for Next-generation Technology – 5G, IoT, AI, Big Data and Beyond. MWC Shanghai has over 60,000 attendees and over 550 participating companies. Mobile World Congress (MWC) Shanghai 2019 will take place from Jun 26-28 in Shanghai New International Expo Centre, Shanghai, China.

 

SOURCE Hong Kong Applied Science and Technology Research Institute (ASTRI)

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending